6,7-Dimorpholinoalkoxy quinazoline derivatives as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells
Keywords: 6,7-Dimorpholinoalkoxy quinazolines; Antiproliferative activities; Epidermal growth factor receptor (EGFR); The Asp855-Phe856-Gly857 (DFG) motif; Tyrosine kinase inhibitors (TKIs);